Genertec medical sees significant stake boost for Dragonland after bond conversion

On November 7, 2025, Genertec Universal Medical Group received a conversion notice from Dragonland International Development Limited for $90,000,000 in convertible bonds. This conversion resulted in the allotment of 122,665,263 new shares at a conversion price of HK$5.7 per share. These new shares represent approximately 6.48% of the company's issued share capital immediately before the conversion and 6.09% after.

Following the conversion, Dragonland International Development Limited's shareholding in Genertec Universal Medical Group increased significantly from 1,707,500 shares (0.09%) to 124,372,763 shares (6.17%). The total issued share capital of the company has now risen to 2,014,204,924 shares, up from 1,891,539,661 shares. The newly issued shares rank pari passu with existing shares.